SCHEMBL29593843

SCHEMBL29593843

Cc1c(Cl)cccc1/C=C(\F)B1OC(C)(C)C(C)(C)O1

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23633041 1.00 ALDH1A1 (0.32) ALDH1A1
SCHEMBL21623040 1.00 ALDH1A1 (0.32) ALDH1A1
SCHEMBL29945088 0.84 APLNR (0.30) —
SCHEMBL28863825 0.84 APLNR (0.30) —
SCHEMBL28863827 0.84 APLNR (0.30) —
SCHEMBL25891666 0.83 — —
SCHEMBL24311194 0.80 PDCD1 (0.38) —
SCHEMBL30340515 0.74 ALDH1A1 (0.42) ALDH1A1
SCHEMBL21622907 0.74 ALDH1A1 (0.42) ALDH1A1
SCHEMBL23633030 0.72 PIM1 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12473282-B2 Biphenyl fluorine double bond derivative, preparation method therefor, and pharmaceutical application thereof ABBISKO THERAPEUTICS CO., LTD. (CN) 2025-11-18 — — US disclosed
US-20230014651-A1 BIPHENYL FLUORINE DOUBLE BOND DERIVATIVE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL APPLICATION THEREOF ABBISKO THERAPEUTICS CO., LTD. (CN) 2023-01-19 — — US disclosed
EP-4089091-A1 BIPHENYL FLUORINE DOUBLE BOND DERIVATIVE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL APPLICATION THEREOF Abbisko Therapeutics Co., Ltd. (CN) 2022-11-16 — — EP disclosed
CN-114502556-A Biphenyl fluoro double bond derivative and preparation method and pharmaceutical application thereof 上海和誉生物医药科技有限公司 2022-05-13 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12473282-B2 Biphenyl fluorine double bond derivative, preparation method therefor, and pharmaceutical application thereof PDCD1, CD274, PDCD1LG2 ALDH1A1 171/4885
US-20230014651-A1 BIPHENYL FLUORINE DOUBLE BOND DERIVATIVE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL APPLICATION THEREOF PDCD1, CD274, PDCD1LG2 ALDH1A1 171/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback